| Trial ID: | L2966 |
| Source ID: | NCT01374568
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Changes in Bone Turnover With Increased Incretin Hormone Exposure
|
| Acronym: |
DRTC
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01374568/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: sitagliptin|OTHER: Placebo
|
| Outcome Measures: |
Primary: Bone Turnover in Subjects Treated With Sitagliptin When Compared to Those Treated With Placebo., Bone turnover assessed using change in TRACP5b over 8 weeks of treatment., 8 weeks|Bone Turnover in Subjects Treated With Sitagliptin When Compared to Those Treated With Placebo, Bone turnover assessed using change in bone-specific alkaline phosphatase (BAP) over 8 weeks of treatment., 8 WEEKS |
|
| Sponsor/Collaborators: |
Sponsor: University of Alabama at Birmingham
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
6
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
|
| Start Date: |
2010-07
|
| Completion Date: |
2015-09
|
| Results First Posted: |
2017-05-31
|
| Last Update Posted: |
2017-07-24
|
| Locations: |
University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01374568
|
